However, it can also present as multiple lesions, particularly in association with syndromes such as neurofibromatosis type-2 and schwannomatosis, which are linked to genetic mutations in the NF2 gene and the tumor suppressor genes SMARCB1 and LZTR1, respectively [5,10,11]. This evidence concerns the gene SMARCB1 and neurofibromatosis.